172 related articles for article (PubMed ID: 212684)
1. Subsensitivity of the rat striatal dopaminergic system after treatment with bromocriptine: effects on [3H]spiperone binding and dopamine-stimulated cyclic AMP formation.
Quik M; Iversen LL
Naunyn Schmiedebergs Arch Pharmacol; 1978 Sep; 304(2):141-5. PubMed ID: 212684
[TBL] [Abstract][Full Text] [Related]
2. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
[TBL] [Abstract][Full Text] [Related]
3. Receptor-linked cyclic AMP systems in rat neostriatum: differential localization revealed by kainic acid injection.
Minneman KP; Quik M; Emson PC
Brain Res; 1978 Aug; 151(3):507-21. PubMed ID: 27287
[TBL] [Abstract][Full Text] [Related]
4. Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra.
Quik M; Emson PC; Joyce E
Brain Res; 1979 May; 167(2):355-65. PubMed ID: 36204
[TBL] [Abstract][Full Text] [Related]
5. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):73-82. PubMed ID: 1321630
[TBL] [Abstract][Full Text] [Related]
6. Functional distinction between DA-stimulated adenylate cyclase and 3H-spiperone binding sites in rat striatum.
Waddington JL; Cross AJ; Longden A; Owen F; Poulter M
Eur J Pharmacol; 1979 Oct; 58(3):341-2. PubMed ID: 510367
[No Abstract] [Full Text] [Related]
7. The effect of chronic bromocriptine and L-dopa on spiperone binding and apomorphine-induced stereotypy.
Globus M; Bannet J; Lerer B; Belmaker RH
Psychopharmacology (Berl); 1982; 78(1):81-4. PubMed ID: 6815701
[TBL] [Abstract][Full Text] [Related]
8. Chronic lead exposure alters dopaminergic mechanisms in rat pituitary.
Lucchi L; Govoni S; Memo M; Missale C; Spano PF; Trabucchi M
Toxicol Lett; 1986 Sep; 32(3):255-60. PubMed ID: 3022429
[TBL] [Abstract][Full Text] [Related]
9. Is there a connection between high affinity 3H-spiperone binding sites and DA-sensitive adenylate cyclase in corpus striatum?
Marchais D; Bockaert J
Biochem Pharmacol; 1980 May; 29(10):1331-6. PubMed ID: 7053066
[No Abstract] [Full Text] [Related]
10. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
Bennett JP; Wooten GF
Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
[TBL] [Abstract][Full Text] [Related]
11. Effects of bromocriptine on 3H-spiroperidol binding sites in rat striatum. Evidence for actions of dopamine receptors not linked to adenylate cyclase.
Schwarcz R; Fuxe K; Agnati LF; Gustafsson JA
Life Sci; 1978 Aug; 23(5):465-9. PubMed ID: 692269
[No Abstract] [Full Text] [Related]
12. Neonatal dopamine lesion in the rat results in enhanced adenylate cyclase activity without altering dopamine receptor binding or dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein (DARPP-32) immunoreactivity.
Luthman J; Lindqvist E; Young D; Cowburn R
Exp Brain Res; 1990; 83(1):85-95. PubMed ID: 1981564
[TBL] [Abstract][Full Text] [Related]
13. Effects of bromocriptine on adenylate cyclase and phosphodiesterase activities of rat striatum.
Pagnini G; Camanni F; Crispino A; Portaleone P
J Pharm Pharmacol; 1978 Feb; 30(2):92-5. PubMed ID: 24111
[TBL] [Abstract][Full Text] [Related]
14. Correlation between drug-induced supersensitivity of dopamine dependent striatal mechanisms and the increase in striatal content of the Ca2+ regulated protein activator of cAMP phosphodiesterase.
Gnegy ME; Lucchelli A; Costa E
Naunyn Schmiedebergs Arch Pharmacol; 1977 Dec; 301(2):121-7. PubMed ID: 202883
[TBL] [Abstract][Full Text] [Related]
15. Guanine nucleotides reveal differential actions of ergot derivatives at D-2 receptors labelled by [3H]spiperone in striatal homogenates.
Gundlach AL; Krstich M; Beart PM
Brain Res; 1983 Nov; 278(1-2):155-63. PubMed ID: 6227373
[TBL] [Abstract][Full Text] [Related]
16. Effect of chronic ethanol treatment on adenylate cyclase activity in rat striatum.
Lucchi L; Covelli V; Anthopoulou H; Spano PF; Trabucchi M
Neurosci Lett; 1983 Sep; 40(2):187-92. PubMed ID: 6314211
[TBL] [Abstract][Full Text] [Related]
17. Apomorphine-induced rotation in the unilateral 6-OHDA-lesioned rat: relationship to changes in striatal adenylate cyclase activity and 3H-spiperone binding.
Waddington JL; Cross AJ; Longden A; Owen F; Poulter M
Neuropharmacology; 1979 Jul; 18(7):643-5. PubMed ID: 573871
[No Abstract] [Full Text] [Related]
18. Bromocriptine and lisuride stimulate the accumulation of cyclic AMP in intact slices but not in homogenates of rat neostriatum.
Saiani L; Trabucchi M; Tonon GC; Spano PF
Neurosci Lett; 1979 Sep; 14(1):31-6. PubMed ID: 231228
[TBL] [Abstract][Full Text] [Related]
19. Age related differences in dopamine-stimulated adenylate cyclase sensitivity to "in vivo" chronic ethanol treatment.
Lucchi L; Govoni S; Trabucchi M
Alcohol; 1984; 1(4):263-7. PubMed ID: 6100231
[TBL] [Abstract][Full Text] [Related]
20. D2 dopamine receptors associated with inhibition of dopamine release from rat neostriatum are independent of cyclic AMP.
Memo M; Missale C; Carruba MO; Spano PF
Neurosci Lett; 1986 Nov; 71(2):192-6. PubMed ID: 2878398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
